| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0096 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.01 | 1 |